Croda International Plc (LON:CRDA – Get Free Report) insider Stephen Oxley sold 1,339 shares of the company’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of GBX 3,214, for a total transaction of £43,035.46.
Stephen Oxley also recently made the following trade(s):
- On Friday, July 10th, Stephen Oxley acquired 5 shares of Croda International stock. The shares were acquired at an average cost of GBX 2,859 per share, for a total transaction of £142.95.
- On Wednesday, June 10th, Stephen Oxley bought 5 shares of Croda International stock. The shares were acquired at an average price of GBX 2,965 per share, with a total value of £148.25.
Croda International Stock Performance
Croda International stock opened at GBX 3,315 on Friday. The stock’s 50 day moving average is GBX 3,031.44 and its 200 day moving average is GBX 2,927.26. The company has a market capitalization of £4.62 billion, a P/E ratio of 58.26, a PEG ratio of 1.40 and a beta of 0.92. Croda International Plc has a twelve month low of GBX 2,426.77 and a twelve month high of GBX 3,352. The company has a quick ratio of 2.25, a current ratio of 2.57 and a debt-to-equity ratio of 36.06.
Analyst Ratings Changes
CRDA has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a GBX 3,300 target price on shares of Croda International in a research note on Wednesday, July 29th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 3,500 price objective on shares of Croda International in a research report on Wednesday, July 29th. Citigroup lifted their target price on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 3,600 target price on shares of Croda International in a report on Wednesday, July 29th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Croda International currently has an average rating of “Moderate Buy” and a consensus price target of GBX 3,390.
Check Out Our Latest Analysis on CRDA
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Recommended Stories
- Five stocks we like better than Croda International
- Western Digital Stock Falls 12% Despite Beating Earnings Estimates
- One Comment on CVS’s Earnings Call Sent the Stock Tumbling
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
